According to Abivax's latest financial reports the company has NZ$0.51 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | NZ$0.45 B | 901.98% |
2022-12-31 | NZ$45.53 M | -54.76% |
2021-12-31 | NZ$0.10 B | 101.49% |
2020-12-31 | NZ$49.95 M | 207.34% |
2019-12-31 | NZ$16.25 M | -26.71% |
2018-12-31 | NZ$22.17 M | -22.94% |
2017-12-31 | NZ$28.77 M | -17.56% |
2016-12-31 | NZ$34.9 M | -44.16% |
2015-12-31 | NZ$62.5 M | 1277.2% |
2014-12-31 | NZ$4.53 M | -18.36% |
2013-12-31 | NZ$5.55 M |